Lincoln Capital LLC Boosts Stock Holdings in Danaher Corporation $DHR

Lincoln Capital LLC lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 7.7% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 98,292 shares of the conglomerate’s stock after acquiring an additional 7,008 shares during the quarter. Danaher comprises 3.9% of Lincoln Capital LLC’s holdings, making the stock its 6th biggest position. Lincoln Capital LLC’s holdings in Danaher were worth $21,909,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. Veery Capital LLC boosted its position in shares of Danaher by 3.1% in the 3rd quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock valued at $350,000 after purchasing an additional 48 shares during the period. Studio Investment Management LLC raised its holdings in Danaher by 3.3% during the 2nd quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after buying an additional 51 shares during the period. Clal Insurance Enterprises Holdings Ltd lifted its stake in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares in the last quarter. JDH Wealth Management LLC boosted its holdings in shares of Danaher by 4.5% in the first quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock worth $240,000 after buying an additional 55 shares during the period. Finally, OLD Second National Bank of Aurora increased its position in shares of Danaher by 0.5% in the first quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate’s stock worth $2,297,000 after acquiring an additional 57 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Up 1.2%

NYSE:DHR traded up $2.69 during mid-day trading on Friday, reaching $220.15. The stock had a trading volume of 3,934,329 shares, compared to its average volume of 4,457,726. The stock has a market cap of $154.76 billion, a P/E ratio of 39.10, a PEG ratio of 2.72 and a beta of 0.76. The business’s 50 day moving average is $211.38 and its 200 day moving average is $194.62. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the prior year, the company posted $0.77 earnings per share. Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. As a group, sell-side analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s payout ratio is presently 28.42%.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of recent analyst reports. The Goldman Sachs Group raised their price objective on shares of Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. UBS Group assumed coverage on Danaher in a report on Wednesday, September 9th. They set a “buy” rating and a $250.00 price target on the stock. Finally, Barclays upped their price target on Danaher from $230.00 to $255.00 and gave the company an “overweight” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $235.23.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.